Awards
Silvia G. Priori to Receive ACC Valentin Fuster Award for Innovation in Science
Dra. Silvia G. Priori has been awarded the 2025 Valentin Fuster Award for Innovation in Science by the American College of Cardiology in honor of their remarkable contributions to the cardiovascular profession. The Valentin Fuster Award for Innovation in Science recognizes an ACC member who has made significant contributions to cardiovascular medicine as a champion of scientific research, an innovator in the delivery of science through novel mechanisms and an international voice on the importance of embracing scientific inquiry to improve the care of cardiovascular patients and promote heart health.
Tribute to Dr Valentín Fuster at the Jiménez Díaz Foundation
Dr. Valentín Fuster General Director of the Spanish National Centre for Cardiovascular Research (CNIC) led the second session of the series of conferences organised by the Fundación Jiménez Díaz (FJD) University Hospital to celebrate its 90th Anniversary. In conversation with Dr Borja Ibáñez, the CNIC’s Scientific Director and FJD cardiologist, Dr Fuster spoke about medical vocation, the value of mentors and the need for human-centred medicine.
An audience of almost 300 filled the hospital’s main lecture hall to hear Fuster speak about his personal trajectory, ranging from his childhood or training in Edinburgh to his leadership at Mount Sinai in New York. “Technology cannot replace a human relationship, only complement it. We need to recover the clinical gaze, physical examination and, above all, listen to the patient,” he said, highlighting his advocacy of medicine based on empathy and service
International Day of Women and Girls in Science
The CNIC celebrated International Day of Women and Girls in Science with inspiring activities to promote STEM careers, highlighting female talent and its training programs.
In addition, on the occasion of International Women’s Day (March 8) and European Cardiovascular Risk Prevention Day (March 14), the CNIC organized a special event aimed at the general public that addressed cardiovascular risk prevention in women.
CNIC research into cardiotoxicity in cancer wins the AECC prize for best scientific article of 2024
The article entitled “Anthracycline Cardiotoxicity Induces Progressive Changes in Myocardial Metabolism and Mitochondrial Quality Control: Novel Therapeutic Target”, whose first author is the CNIC researcher Anabel Díaz-Guerra, was awarded first prize for the best scientific article of 2024 written by recipients of the AECC Predoctoral Grants. Her research, published in the review JACC: CardioOncology. identified possible therapies for the cardiotoxicity of anthracyclines, drugs habitually used in cancer treatment, which is estimated to affect a third of people who survive cancer.
Cardiovascular disease in women: a call for action from Europe
On International Women’s Day, the European Parliament hosted the event “A wake-up call: Key trends and policy issues in cardiovascular health for women and girls,” which addressed gender inequalities in cardiovascular disease. Dr. María Rubini, cardiologist and researcher at the CNIC and chair of the European Society of Cardiology’s Gender Working Group, actively participated with a presentation that highlighted the urgent need to raise awareness, promote gender-sensitive research, and encourage the inclusion of women in clinical trials. Rubini called on policymakers to integrate the gender perspective into the EU Cardiovascular Health Plan and the Equality Strategy, positioning the CNIC as a key voice in the fight for more equitable cardiovascular health for women. ‘It is essential to raise awareness of CVD in women, as it is the leading cause of death in the EU, with more deaths than all cancers combined,’ she said.
CNIC, participant in the International Be Open About Animal Research Day
CNIC participated in the International Be Open About Animal Research Day organised by the European Animal Research Association (EARA), the international organisation that highlights the importance of responsible, regulated animal research limited to experiments that cannot yet be conducted without them.
CNIC at the European Meeting on Science, Technology, and Innovation
The Spanish National Centre for Cardiovascular Research (CNIC) is again an active participant in the European Meeting on Science, Technology, and Innovation (Transfiere) 2025. The event is the main meeting for R+D in the south of Europe and its aim is to share scientific and technological knowledge, promote innovation, connect science and business, and facilitate the transfer of knowledge so that scientific and technological developments reach people’s daily lives.
CNIC at the 2024 Science Week
From November 7 to 15, CNIC organized 11 activities during the 24th Science and Innovation Week, welcoming participants of all ages. Attendees engaged in practical workshops and had the chance to visit CNIC’s state-of-the-art laboratories.
CNIC obtains the “Equality in the Workplace” (DIE) distinction from the Women’s Institute
The CNIC has obtained the “Equality in the Workplace” (DIE) distinction, awarded by the Ministry of Equality through the Women’s Institute, in recognition of its commitment and excellence in the application of equality policies. This distinction, which will be valid for five years, also means that the CNIC will join the DIE Network, a platform for the exchange of best practices among the 197 organizations recognized for their work in promoting equal treatment and opportunities for women and men in the workplace.
4th ESO Program at CNIC
CNIC participates in the 4th ESO+Company Program of the Community of Madrid, opening its doors to offer educational stays to interested students from public or charter schools. This program at CNIC seeks to bring the educational system closer to the field of cardiovascular scientific research.
Visit by the Mapfre Foundation to the CNIC
Visit by the University of Shanghai to the CNIC
Visit by representatives of the State Attorney’s Office to the CNIC
